
Statera Biopharma is a drug development company focused on restoring immune health by bringing the immune system back into homeostasis. Their approach leverages complex, pleiotropic beneficial effects, developing drugs that act as natural analogs and trans-activators to resolve disease. The company's principles include restoration and balance, comprehensive and complex multi-component systems (AIMS), safety and foresight with a BENEFIT/risk focus, pleiotropic analogs, multiple pathways and aggregate effects, systems biology and evolving therapeutics using AI, and roundtrip development utilizing in-human findings. Their team includes experienced professionals in finance, technology, clinical operations, and leadership with backgrounds in life sciences, drug commercialization, and research.

Statera Biopharma is a drug development company focused on restoring immune health by bringing the immune system back into homeostasis. Their approach leverages complex, pleiotropic beneficial effects, developing drugs that act as natural analogs and trans-activators to resolve disease. The company's principles include restoration and balance, comprehensive and complex multi-component systems (AIMS), safety and foresight with a BENEFIT/risk focus, pleiotropic analogs, multiple pathways and aggregate effects, systems biology and evolving therapeutics using AI, and roundtrip development utilizing in-human findings. Their team includes experienced professionals in finance, technology, clinical operations, and leadership with backgrounds in life sciences, drug commercialization, and research.